FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

733464008: Ocrelizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3499483013 Ocrelizumab en Synonym Active Entire term case insensitive SNOMED CT core module
3499484019 Ocrelizumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ocrelizumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Ocrelizumab Is a Substance with immunomodulator mechanism of action true Inferred relationship Existential restriction modifier
Ocrelizumab Has disposition Immunomodulator true Inferred relationship Existential restriction modifier
Ocrelizumab Is a Immunologic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing ocrelizumab Has active ingredient True Ocrelizumab Inferred relationship Existential restriction modifier 1
Product containing ocrelizumab in parenteral dose form (medicinal product form) Has active ingredient True Ocrelizumab Inferred relationship Existential restriction modifier 1
Ocrelizumab Has active ingredient True Ocrelizumab Inferred relationship Existential restriction modifier 1
Product containing only ocrelizumab in parenteral dose form (medicinal product form) Has active ingredient True Ocrelizumab Inferred relationship Existential restriction modifier 1
Ocrelizumab therapy Direct substance True Ocrelizumab Inferred relationship Existential restriction modifier 1
Ocrelizumab 300mg/10ml solution for infusion vials Has specific active ingredient True Ocrelizumab Inferred relationship Existential restriction modifier
Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) Has specific active ingredient False Ocrelizumab Inferred relationship Existential restriction modifier
Ocrelizumab 300mg/10ml solution for infusion vials 1 vial Has specific active ingredient True Ocrelizumab Inferred relationship Existential restriction modifier
Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has specific active ingredient False Ocrelizumab Inferred relationship Existential restriction modifier
Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) Has specific active ingredient True Ocrelizumab Inferred relationship Existential restriction modifier
Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has specific active ingredient True Ocrelizumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start